Follow

Manuscripts from 2010

PDF

Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute., Thomas Force, Robert O Bonow, Steven R Houser, R John Solaro, Ray E Hershberger, Bishow Adhikari, Mark E Anderson, Robin Boineau, Barry J Byrne, Thomas P Cappola, Raghu Kalluri, Martin M LeWinter, Martin S Maron, Jeffery D Molkentin, Steve R Ommen, Michael Regnier, W H Wilson Tang, Rong Tian, Marvin A Konstam, Barry J Maron, and Christine E Seidman

PDF

GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in mice., Jibin Zhou, Hind Lal, Xiongwen Chen, Xiying Shang, Jianliang Song, Yingxin Li, Risto Kerkela, Bradley W Doble, Katrina MacAulay, Morgan DeCaul, Walter J Koch, John Farber, James Woodgett, Erhe Gao, and Thomas Force

Manuscripts from 2009

PDF

An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo., Anastasios Lymperopoulos, Giuseppe Rengo, Carmela Zincarelli, Jihee Kim, Stephen Soltys, and Walter J Koch

Manuscripts from 2008

PDF

Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation., Risto Kerkela, Lisa Kockeritz, Katrina Macaulay, Jibin Zhou, Bradley W. Doble, Cara Beahm, Sarah Greytak, Kathleen Woulfe, Chinmay M. Trivedi, James R. Woodgett, Jonathan A. Epstein, Thomas Force, and Gordon S. Huggins

Manuscripts from 2007

PDF

Beta blocker specificity: a building block toward personalized medicine., Brent R DeGeorge and Walter J Koch

Manuscripts from 2006

PDF

P5L mutation in Ank results in an increase in extracellular inorganic pyrophosphate during proliferation and nonmineralizing hypertrophy in stably transduced ATDC5 cells, Raihana Zaka, David Stokes, Arnold S. Dion, Anna Kusnierz, Fei Han, and Charlene J. Williams